Surface Oncology, Inc.

Surface Oncology, Inc.verified

SURF

Price:

$1.07

Market Cap:

$65.08M

Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibody that inhibits CD39 enzymatic activity for the production of adenosine and the breakdown of adenosine triphosphate; SRF388 targeting interleukin 27; GSK4381562, an antibody targeting CD112R, an inhibitory protein expressed on natural killer and T cells; and SRF114 targeting the chemokine receptor CCR8. Surface Oncology, Inc. has a license agreement ...[Read more]

Industry

Biotechnology

IPO Date

2018-04-19

Stock Exchange

NASDAQ

Ticker

SURF

The Enterprise Value as of November 2024 (TTM) for Surface Oncology, Inc. (SURF) is 59.73M

According to Surface Oncology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 59.73M. This represents a change of 6.67% compared to the average of 55.99M of the last 4 quarters.

Surface Oncology, Inc. (SURF) Historical Enterprise Value (quarterly & annually)

How has SURF Enterprise Value performed in the past?

The mean historical Enterprise Value of Surface Oncology, Inc. over the last ten years is 132.84M. The current 59.73M Enterprise Value has changed 4.40% with respect to the historical average. Over the past ten years (40 quarters), SURF's Enterprise Value was at its highest in in the September 2021 quarter at 328.65M. The Enterprise Value was at its lowest in in the December 2018 quarter at -41454840.00.

Quarterly (TTM)
Annual

Average

132.84M

Median

212.75M

Minimum

-74073160.00

Maximum

247.79M

Surface Oncology, Inc. (SURF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Surface Oncology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 639.15%

Maximum Annual Enterprise Value = 247.79M

Minimum Annual Increase = -141.38%

Minimum Annual Enterprise Value = -74073160.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202250.85M-76.10%
2021212.75M-6.10%
2020226.56M639.15%
201930.65M-141.38%
2018-74073160.00-131.48%
2017235.33M-5.03%

Surface Oncology, Inc. (SURF) Average Enterprise Value

How has SURF Enterprise Value performed in the past?

The current Enterprise Value of Surface Oncology, Inc. (SURF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

163.39M

5-year avg

89.35M

10-year avg

132.84M

Surface Oncology, Inc. (SURF) Enterprise Value vs. Peers

How is SURF’s Enterprise Value compared to its peers?

Surface Oncology, Inc.’s Enterprise Value is greater than Syros Pharmaceuticals, Inc. (26.07M), less than Repare Therapeutics Inc. (74.31M), less than Personalis, Inc. (264.29M), greater than Evogene Ltd. (2.54M), less than Iovance Biotherapeutics, Inc. (3.33B),

CompanyEnterprise ValueMarket cap
26.07M$65.20M
74.31M$151.95M
264.29M$265.37M
2.54M$11.21M
3.33B$3.47B

Build a custom stock screener for Surface Oncology, Inc. (SURF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Surface Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Surface Oncology, Inc. (SURF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Surface Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Surface Oncology, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Surface Oncology, Inc. (SURF)?

What is the 3-year average Enterprise Value for Surface Oncology, Inc. (SURF)?

What is the 5-year average Enterprise Value for Surface Oncology, Inc. (SURF)?

How does the current Enterprise Value for Surface Oncology, Inc. (SURF) compare to its historical average?